Table 4.
SNP | Genotype | Controls (%) | Adenocarcinoma (%) | Adjusted OR a | 95% CI | p |
---|---|---|---|---|---|---|
N = 395 | N = 321 | |||||
rs7813 | TT | 153 (38.7) | 170 (53.0) | Ref | ||
CT | 193 (48.9) | 118 (36.8) | 0.550 | 0.401, 0.755 | <0.001 * | |
CC | 49 (12.4) | 33 (10.3) | 0.595 | 0.362, 0.976 | 0.040 * | |
Dominant model | CT + CC | 242 (61.3) | 151 (47.0) | 0.562 | 0.417, 0.757 | <0.001 * |
Additive model | C allele | 0.689 | 0.551, 0.862 | 0.001 * | ||
rs2740349 | AA | 298 (75.4) | 259 (80.7) | Ref | ||
AG | 86 (21.8) | 59 (18.4) | 0.788 | 0.543, 1.141 | 0.207 | |
GG | 11 (2.8) | 3 (0.9) | 0.313 | 0.086, 1.134 | 0.077 | |
Dominant model | AG + GG | 97 (24.6) | 62 (19.3) | 0.734 | 0.512, 1.052 | 0.093 |
Additive model | G allele | 0.711 | 0.513, 0.987 | 0.041 * | ||
rs2291778 | GG | 214 (54.2) | 150 (46.7) | Ref | ||
GT | 150 (38.0) | 134 (41.7) | 1.275 | 0.932, 1.745 | 0.128 | |
TT | 31 (7.8) | 37 (11.5) | 1.719 | 1.017, 2.904 | 0.043 * | |
Dominant model | GT + TT | 181 (45.8) | 171 (53.3) | 1.354 | 1.006, 1.821 | 0.045 * |
Additive model | T allele | 1.307 | 1.040, 1.642 | 0.021 * | ||
rs910924 | CC | 277 (70.1) | 261 (81.3) | Ref | ||
CT | 108 (27.3) | 55 (17.1) | 0.540 | 0.374, 0.779 | 0.001 * | |
TT | 10 (2.5) | 5 (1.6) | 0.533 | 0.180, 1.582 | 0.257 | |
Dominant model | CT + TT | 118 (29.9) | 60 (18.7) | 0.540 | 0.379, 0.769 | 0.001 * |
Additive model | T allele | 0.583 | 0.424, 0.802 | 0.001 * | ||
rs595961 | GG | 285 (72.2) | 198 (61.7) | Ref | ||
AG | 102 (25.8) | 112 (34.9) | 1.580 | 1.143, 2.184 | 0.006 * | |
AA | 8 (2.0) | 11 (3.4) | 1.982 | 0.783, 5.018 | 0.149 | |
Dominant model | AG + AA | 110 (27.8) | 123 (38.3) | 1.609 | 1.175, 2.205 | 0.003 * |
Additive model | A allele | 1.502 | 1.143, 1.974 | 0.003 * |
a Adjusted for age, ORs and 95% CIs were calculated by logistic regression; * p < 0.05. Bold values indicate significance after Bonferroni correction (k = 8).